Search research articles
Contact Us
Filters
Showing results (41-50 of 369) with videos related to
Page
of 37
Sort By:
Reviews in Medical Virology
|
October 6, 2011
The type I interferon response during viral infections: a "SWOT" analysis
Giel R Gaajetaan, Cathrien A Bruggeman, Frank R Stassen
The Journal of General Virology
|
November 26, 1999
The rat cytomegalovirus R32 gene encodes a virion-associated protein that elicits a strong humoral immune response in infected rats
Erik Beuken, Gert Grauls, Cathrien A Bruggeman, et al.
Journal of the American Society of Nephrology : JASN
|
February 16, 2017
Identifying the Intracellular Function of APOL1
Leslie A Bruggeman, John F O'Toole, John R Sedor
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 20, 2021
APOL1 and Preeclampsia: Intriguing Links, Uncertain Causality, Troubling Implications
John R Sedor, Leslie A Bruggeman, John F O'Toole
Current Opinion in Nephrology and Hypertension
|
March 26, 2021
Apolipoprotein L1 and mechanisms of kidney disease susceptibility
Leslie A Bruggeman, John R Sedor, John F O'Toole
New Directions for Youth Development
|
July 26, 2011
A competency-based approach to preparing staff as recreation and youth development leaders
Robert J Barcelona, Amy R Hurd, Jennifer A Bruggeman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 13, 2017
A New Mouse Model of APOL1-Associated Kidney Diseases: When Traffic Gets Snarled, the Podocyte Suffers
John F O'Toole, Leslie A Bruggeman, John R Sedor
American Journal of Physiology. Renal Physiology
|
October 18, 2018
APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
Leslie A Bruggeman, John F O'Toole, John R Sedor
Antiviral Research
|
November 7, 1999
Cytomegalovirus and atherogenesis
C A Bruggeman, H J Marjorie, G Nelissen-Vrancken
Transplantation Proceedings
|
December 1, 1995
Initial endothelial injury and cytomegalovirus infection accelerate the development of allograft arteriosclerosis
F Li, G Grauls, M Yin, et al.
Page
of 37
Search research articles
Search
Showing results (41-50 of 369) with videos related to
Sort By:
Page
of 37
Reviews in Medical Virology
|
October 6, 2011
The type I interferon response during viral infections: a "SWOT" analysis
Giel R Gaajetaan, Cathrien A Bruggeman, Frank R Stassen
The Journal of General Virology
|
November 26, 1999
The rat cytomegalovirus R32 gene encodes a virion-associated protein that elicits a strong humoral immune response in infected rats
Erik Beuken, Gert Grauls, Cathrien A Bruggeman, et al.
Journal of the American Society of Nephrology : JASN
|
February 16, 2017
Identifying the Intracellular Function of APOL1
Leslie A Bruggeman, John F O'Toole, John R Sedor
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
April 20, 2021
APOL1 and Preeclampsia: Intriguing Links, Uncertain Causality, Troubling Implications
John R Sedor, Leslie A Bruggeman, John F O'Toole
Current Opinion in Nephrology and Hypertension
|
March 26, 2021
Apolipoprotein L1 and mechanisms of kidney disease susceptibility
Leslie A Bruggeman, John R Sedor, John F O'Toole
New Directions for Youth Development
|
July 26, 2011
A competency-based approach to preparing staff as recreation and youth development leaders
Robert J Barcelona, Amy R Hurd, Jennifer A Bruggeman
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
August 13, 2017
A New Mouse Model of APOL1-Associated Kidney Diseases: When Traffic Gets Snarled, the Podocyte Suffers
John F O'Toole, Leslie A Bruggeman, John R Sedor
American Journal of Physiology. Renal Physiology
|
October 18, 2018
APOL1 polymorphisms and kidney disease: loss-of-function or gain-of-function?
Leslie A Bruggeman, John F O'Toole, John R Sedor
Antiviral Research
|
November 7, 1999
Cytomegalovirus and atherogenesis
C A Bruggeman, H J Marjorie, G Nelissen-Vrancken
Transplantation Proceedings
|
December 1, 1995
Initial endothelial injury and cytomegalovirus infection accelerate the development of allograft arteriosclerosis
F Li, G Grauls, M Yin, et al.
Page
of 37